EM•1® for Aquaculture: Proven Probiotic Technology for Shrimp and Fish Production

This page covers commercial aquaculture applications of EM•1® — shrimp farming, fish production, larval rearing, and pond water quality management. For wastewater and effluent treatment from aquaculture operations, see EM•1® for Wastewater Treatment.

Aquaculture is one of the fastest-growing food production sectors in the world — and one of the most biologically demanding. Water quality, pathogen pressure, feed conversion efficiency, and larval survival rates are all determined by the microbial ecology of the production system. When that ecology is healthy and balanced, aquaculture operations are productive and resilient. When it is disrupted — by disease pressure, chemical inputs, or overcrowding — losses can be catastrophic.

EM•1® Microbial Inoculant, manufactured by EMRO USA under authorization from EM Research Organization, Inc. (Japan), has been applied in commercial aquaculture operations worldwide for decades. It is the only EM Technology® product manufactured in the United States, and it is backed by peer-reviewed research — including published University of Arizona studies specifically investigating EM•1®'s performance in shrimp production systems.

This page is for commercial shrimp and fish producers, hatchery operators, aquaculture consultants, and feed companies looking to incorporate proven probiotic biology into their production programs. Contact EMRO USA for volume pricing and technical program support.

73.3%
shrimp survival in published AHPND challenge study — highest of all treatments tested
31.2%
weight increase in EM•1®-treated shrimp vs. other probiotic groups in peer-reviewed trial
40+
years of EM Technology® application in aquaculture worldwide
100+
countries using EM Technology® across agriculture and aquaculture

The science: peer-reviewed research on EM•1® in shrimp aquaculture

EM•1® is one of the few commercial aquaculture probiotics with published, peer-reviewed research specifically evaluating its performance in shrimp production systems. The following studies were conducted at the University of Arizona and published in international scientific journals.

Pinoargote et al. (2018) — Aquaculture Research (Wiley)

This study evaluated the effects of four probiotic formulations on Pacific white shrimp (Litopenaeus vannamei) infected with the pathogenic strain of Vibrio parahaemolyticus responsible for Acute Hepatopancreatic Necrosis Disease (AHPND) — one of the most devastating diseases affecting global shrimp production. Four treatments were compared: single-strain Lactobacillus casei, two multi-strain combinations, and EM•1® (the commercial probiotic treatment).

Key findings: EM•1® achieved 73.3% shrimp survival — the highest of all four probiotic treatments tested, and dramatically higher than the untreated infected control (0% survival at 20 hours). Shrimp treated with EM•1® also showed the highest weight increase (31.2%) among all treatment groups. Critically, microbial diversity in the gastrointestinal tract of EM•1®-treated shrimp was maintained or increased following AHPND infection — uniquely resembling the uninfected control group — while all other probiotic treatments showed significant post-infection collapse in GIT microbial diversity.

The study concluded that the multi-species culture in EM•1® — combining lactic acid bacteria, yeast, and photosynthetic bacteria — outperformed every single-strain and reduced-combination treatment, confirming that the synergistic diversity of EM•1® is central to its protective efficacy.

Read the full study: DOI 10.1111/are.13791 →

Pinoargote & Ravishankar (2018) — Journal of Probiotics & Health

This companion study evaluated the inhibitory effects of probiotic solutions — including EM•1® — against Vibrio parahaemolyticus in vitro, using both disk diffusion tests and liquid media challenge tests. EM•1® demonstrated the earliest and most consistent bactericidal activity against the AHPND-causing pathogen of all treatments evaluated, with no surviving pathogen detected at 48 hours in the EM•1® treatment group.

The study confirmed that the full multi-species commercial probiotic formulation outperformed isolated individual components, supporting the conclusion that the multi-species effect — not any single organism — drives the efficacy of EM•1® against Vibrio parahaemolyticus.

Read the full study: DOI 10.4172/2329-8901.1000193 →

"The EM treatment had a statistically significant higher survival (73.3%) when compared to the other treatment groups... The diversity indices of the GIT of shrimp treated with EM increased after infection, resembling the changes observed with the negative control in which no infection was induced." — Pinoargote et al., Aquaculture Research, 2018

These studies are published under open-access licenses and are freely available. Links to both papers are included in the EM Technology® Research Library.

How EM•1® works in aquaculture systems

EM•1® is a liquid multi-species culture of naturally occurring beneficial microorganisms — lactic acid bacteria, yeasts, and photosynthetic bacteria — co-fermented into a stable, synergistic community. In aquaculture systems, this diverse microbial community acts on multiple dimensions of the production environment simultaneously:

💧

Water quality maintenance

EM•1® improves key water quality parameters including turbidity, dissolved oxygen, and pH — creating stable conditions that support optimal shrimp and fish health throughout the production cycle.

🦠

Pathogen suppression

Lactic acid bacteria in EM•1® competitively exclude harmful pathogens including Vibrio species — reducing disease pressure in both the water column and the gastrointestinal tract of cultured species.

🔵

Biofloc support

EM•1® promotes the formation of biofloc — stable aggregates of bacteria, algae, and organic particles that serve as a high-value nutritional resource for shrimp larvae and postlarvae while simultaneously improving water clarity.

♻️

Organic matter decomposition

Efficient breakdown of uneaten feed, excretions, and organic waste reduces the accumulation of toxic metabolites — keeping ammonia, hydrogen sulfide, and methane at safe levels without chemical intervention.

🌿

GIT colonization

When applied via feed, EM•1® inoculates the gastrointestinal tract of cultured species with beneficial microorganisms — supporting digestion, nutrient absorption, immune function, and resistance to pathogenic infection.

📈

Feed conversion & growth

Operations applying EM•1® consistently report improvements in feed conversion rates, digestibility, and growth performance — reducing feed costs and improving the economic efficiency of the production cycle.

Shrimp production: the primary application

Shrimp farming — particularly Pacific white shrimp (Litopenaeus vannamei) and black tiger shrimp (Penaeus monodon) — represents the highest-value and most biologically intensive application of EM•1® in aquaculture. The microbial ecology of shrimp ponds is complex and highly dynamic, and the consequences of biological imbalance — disease outbreaks, water quality collapse, mass mortality events — are severe and often irreversible.

AHPND and Vibrio management

Acute Hepatopancreatic Necrosis Disease (AHPND), also known as Early Mortality Syndrome (EMS), has devastated shrimp industries across Asia and the Americas since 2009. Caused by a specific strain of Vibrio parahaemolyticus carrying a binary toxin-producing plasmid, AHPND can cause near-total mortality in affected ponds within days of the first signs of infection. Published peer-reviewed research has demonstrated that EM•1® — applied via both water and feed — provides measurable protection against AHPND, with survival outcomes significantly superior to both untreated controls and single-strain or reduced-combination probiotic treatments.

Why the full muli-species formulation matters

The peer-reviewed research on EM•1® in AHPND challenge studies revealed a critical finding: single-strain probiotic treatments, even those using the same individual organisms present in EM•1®, performed significantly worse than the full commercial formulation. This confirms that the synergistic interactions between lactic acid bacteria, yeasts, and photosynthetic bacteria in EM•1® — not any single component — are responsible for the documented protective outcomes. This is the science behind why authentic EM Technology® cannot be replicated by mixing isolated strains.

Application points in shrimp production

1

Water reservoir treatment

EM•1® is applied to incoming water before it enters the production system — establishing a beneficial microbial baseline and reducing pathogen and organic matter loads before shrimp are introduced.

2

Larval and postlarval rearing

In hatchery and nursery systems, EM•1® maintains water quality, controls ammonium levels, reduces foam formation, promotes biofloc development, and supports clean tank conditions through the most biologically vulnerable stages of the production cycle.

3

Pond water management

Ongoing water column applications throughout the grow-out phase maintain biological balance, suppress pathogen populations, manage organic matter accumulation, and support dissolved oxygen and pH stability.

4

Feed inoculation

EM•1® applied to feed before feeding inoculates the gastrointestinal tract of shrimp with beneficial microorganisms — supporting digestion, improving feed conversion, and establishing a protective microbial community in the gut that competes directly with pathogens.

5

Pond bottom treatment

Applications to pond bottom sediment reduce the accumulation of toxic metabolites, manage hydrogen sulfide production from anaerobic decomposition, and improve the biological conditions of the substrate where shrimp spend the majority of their time.

What shrimp producers have reported

Production parameter Reported outcomes with EM•1®
Survival rates Improved survival documented in both published research and commercial field applications
Growth performance Higher weight gain and improved feed conversion ratios reported consistently
Water quality Measurable improvements in turbidity, dissolved oxygen, ammonia, and pH stability
Pathogen pressure Reduced Vibrio populations in water column and shrimp GIT
Tank and pond cleanliness Operators report significantly less feed accumulation and organic buildup
Harvest quality Shrimp produced with EM•1® programs reported free of contaminants that affect market quality

Fish aquaculture applications

EM•1® is applied across a wide range of fish production systems — from intensive freshwater tank culture to semi-intensive pond systems for tilapia, catfish, salmon, trout, and other species. The same mechanisms that improve shrimp production biology — water quality stabilization, organic matter management, pathogen suppression, and GIT colonization — apply across fish production systems, adapted to the specific water chemistry and biological requirements of each species.

Key water quality parameters that EM•1® supports in fish production include dissolved oxygen stability, ammonia and nitrite control, turbidity reduction, and the management of harmful gas accumulation — particularly hydrogen sulfide from anaerobic sediment decomposition, which is a leading cause of stress and mortality in intensive fish culture systems.

Healthy water, healthy fish

The relationship between water quality and fish health is direct and well-documented. Fish experiencing chronic water quality stress show suppressed immune function, reduced feed intake, impaired growth, and heightened susceptibility to bacterial and parasitic infection. EM•1® addresses the root cause of water quality degradation — biological imbalance — rather than treating symptoms with chemical interventions that disrupt the same biological system they are trying to support.

EM•1® vs. conventional aquaculture health management

Factor Conventional approach With EM•1®
Disease management Reactive — antibiotics and chemical treatments after outbreak Proactive — biological balance that suppresses pathogen establishment
Water quality management Chemical inputs and aeration to manage symptoms Biological management of root causes — organic matter, oxygen demand, pathogen load
Antibiotic dependency High — resistance development an increasing problem Reduced — biological protection reduces the need for antibiotic intervention
Residues in product Antibiotic and chemical residuals — market access risk No residuals — EM•1® is 100% natural and non-toxic
Environmental impact Chemical discharge in effluent — regulatory risk Biologically active effluent — improved treatment outcomes
Long-term system health Degrading — chemical inputs disrupt native biology Improving — beneficial microbial community builds over time

Related EM Technology® applications

💧

EM•1® for wastewater

Biological treatment of aquaculture effluent — reducing organic load, BOD, and pathogen levels before discharge and protecting receiving water bodies.

♻️

EM•1® for composting

Transform aquaculture sludge and organic waste into biologically rich compost — closing the nutrient loop between aquaculture and agriculture.

🌾

EM•1® for agriculture

The same microbial technology that protects shrimp ponds rebuilds soil biology, reduces synthetic nitrogen requirements, and improves crop performance.

🐄

EM•1® for livestock

Probiotic applications in animal production — feed efficiency, gut health, and waste management across poultry, swine, cattle, and other livestock species.

Why source from EMRO USA directly

EMRO USA is the sole authorized manufacturer of EM Technology® products in the United States and Canada, operating under direct agreement with EM Research Organization, Inc. (Japan) since 1998. The peer-reviewed research documenting EM•1®'s performance in shrimp aquaculture was conducted specifically with EMRO USA's commercial product — confirming that the documented outcomes are attributable to the authentic formulation, not to isolated strains or imitation products.

  • OMRI Listed® — certified for use in certified organic production systems
  • Peer-reviewed research — published University of Arizona studies specifically on EM•1® in shrimp production
  • Manufactured in the USA — consistent supply and quality for continuous commercial operations
  • Direct manufacturer support — technical guidance from the people who make the product
  • Commercial and bulk pricing — volume pricing for large-scale aquaculture operations

To understand why authentic EM Technology® cannot be replicated, read our How to Identify Authentic EM Technology® guide. For the full science behind the microbiology, visit What Is EM Technology®? For the complete research record, visit the EM Technology® Research Library.

Ready to bring proven probiotic technology to your aquaculture operation?

Whether you operate a commercial shrimp farm, a fish hatchery, or an integrated aquaculture system — EMRO USA has the product, the published science, and the technical expertise to support your program.

📧 orders@emrousa.com  |  📞 520-492-2010  |  Mon–Fri, 9:00 AM – 5:00 PM MST

Shop EM•1® Microbial Inoculant  |  View all EMRO USA products  |  Request a consultation

EM®, Effective Microorganisms®, EM Technology®, and EM•1® are trademarks of EM Research Organization, Inc. (Japan) and/or EMRO USA, Inc. OMRI Listed® is a registered trademark of the Organic Materials Review Institute. Research citations: Pinoargote G, Flores G, Cooper K, Ravishankar S. Aquaculture Research. 2018. DOI: 10.1111/are.13791. Pinoargote G, Ravishankar S. Journal of Probiotics & Health. 2018. DOI: 10.4172/2329-8901.1000193.